share_log

Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $10

Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $10

坎託·菲茨傑拉德維持對AvePoint的增持,將目標股價提高至10美元
Benzinga ·  2023/08/10 11:33

Cantor Fitzgerald analyst Brett Knoblauch maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $8 to $10.

坎託·菲茨傑拉德分析師佈雷特·諾布勞赫維持AvePoint(納斯達克股票代碼:AVPT)的增持,並將目標股價從8美元上調至10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論